Kidney dehydrogenase

Although MR also binds glucocorticoids, its main ligand in classical mineralocorticoid target tissues such as kidney and colon is aldosterone ( d 1.3 nM). This can be granted to the ability of 11 (3-hydioxysteroid dehydrogenase type II (11 (3-HSD II) to convert active cortisol into its inactive metabolite cortisone in these tissues. Since aldosterone is no substrate for this enzyme it can readily bind to MR, leading to exclusive occupation of the receptor by aldosterone. In contrast, no such mechanism exists in brain and presumably... 

McKelvey, T.G., Hollwarth, M.E., Granger, D.N., Engerson, T.D., Landler, U. and Jones H.P. (1988). Mechanisms of conversion of xanthine dehydrogenase to xanthine oxidase in ischaemic rat liver and kidney. Am. J. Physiol. 254, G753-G760. 

Propylene glycol is partially excreted by the kidney unchanged and partially metabolized by hepatic alcohol dehydrogenase to lactic acid and pyruvate. 

Disulfiram works by irreversibly blocking the enzyme aldehyde dehydrogenase, a step in the metabolism of alcohol, resulting in increased blood levels of the toxic metabolite acetaldehyde. As levels of acetaldehyde increase, the patient experiences decreased blood pressure, increased heart rate, chest pain, palpitations, dizziness, flushing, sweating, weakness, nausea and vomiting, headache, shortness of breath, blurred vision, and syncope. These effects are commonly referred to as the disulfiram-ethanol reaction. Their severity increases with the amount of alcohol that is consumed, and they may warrant emergency treatment. Disulfiram is contraindicated in patients who have cardiovascular or cerebrovascular disease, because the hypotensive effects of the disulfiram-alcohol reaction could be fatal in such patients or in combination with antihypertensive medications. Disulfiram is relatively contraindicated in patients with diabetes, hypothyroidism, epilepsy, liver disease, and kidney disease as well as impulsively suicidal patients. 

Rahmatullah, M. and Roche, T.E. (1985) Modification of bovine kidney pyruvate dehydrogenase kinase activity by CoA esters and their mechanism of action. Journal of Biological Chemistry 260, 10146—10152. 

Intraperitoneal injection of 4-methylpyrazole to rats at 90 mg/kg BW, given 2 h prior to 1080 administration, offered partial protection against accumulations of citrate or fluorocitrate in the kidney (Feldwick et al. 1994). The antidotal effects of 4-methylpyrazole are attributed to its inhibition of NAD+-dependent alcohol dehydrogenase that converts l,3-difluoro-2-propanol to difluoro-acetone, an intermediate in the pathway of erythrofluorocitrate metabolism (Feldwick et al. 1994). A disadvantage of 4-methylpyrazole is that it needs to be administered before significant exposure to fluoroacetate. 

H0. Hess, R., and Gross, F., Glucose-0-phosphate dehydrogenase and renin in kidneys of hypertensive or adrenalectomized rats. Am. J. Physiol. 197, 809-872 (1959). 

Fluoroethanol itself is innocuous towards a variety of tissue constituents, a series of enzymes in rat-liver mince, and the respiration and metabolism in liver, kidney, heart and brain slice.3 After a period of incubation in those tissues known to contain alcohol dehydrogenase, e.g. liver and kidney, the respiration and pyruvate oxidation were strongly inhibited. Likewise, following a period of incubation with yeast, acetate oxidation was blocked. These inhibitions were similar to those produced by fluoroacetate, and the facts can best be explained by the oxidation of fluoroethanol to fluoroacetic acid by alcohol dehydrogenase. 

The retention of 1,2-dibromoethane in tissues and body fluids can be altered by concurrent exposure to modifiers of enzyme activity, such as disulfiram (Plotnick et al. 1979). The concentration of radiolabeled 1,2-dibromoethane in the liver, kidneys, spleen, testes, and brain increased significantly in rats fed disulfiram in the diet for 12 days before an oral dose of 15 mg C-1,2- dibromoethane/kg compared with rats not fed disulfiram. Disulfiram, an inhibitor of P-450 metabolism (via action on acetaldehyde dehydrogenase), was found to increase the uptake of C into liver nuclei. These observations correlate well with the results of chronic studies (Wong et al. 1982) that demonstrated enhanced tumorigenic effects in the liver and testes following combined 1,2-dibromoethane and disulfiram exposure. 

Figure 8.29 The initial reactions of glutamine metabolism in kidney, intestine and cells of the immune system. The initial reaction in all these tissues is the same, glutamine conversion to glutamate catalysed by glutaminase the next reactions are different depending on the function of the tissue or organ. In the kidney, glutamate dehydrogenase produces ammonia to buffer protons. In the intestine, the transamination produces alanine for release and then uptake and formation of glucose in the liver. In the immune cells, transamination produces aspartate which is essential for synthesis of pyrimidine nucleotides required for DNA synthesis otherwise it is released into the blood to be removed by the enterocytes in the small intestine or by cells in the liver.

In the malate shuttle (left)—which operates in the heart, liver, and kidneys, for example-oxaloacetic acid is reduced to malate by malate dehydrogenase (MDH, [2a]) with the help of NADH+HT In antiport for 2-oxogluta-rate, malate is transferred to the matrix, where the mitochondrial isoenzyme for MDH [2b] regenerates oxaloacetic acid and NADH+HT The latter is reoxidized by complex I of the respiratory chain, while oxaloacetic acid, for which a transporter is not available in the inner membrane, is first transaminated to aspartate by aspartate aminotransferase (AST, [3a]). Aspartate leaves the matrix again, and in the cytoplasm once again supplies oxalo-acetate for step [2a] and glutamate for return transport into the matrix [3b]. On balance, only NADH+H"" is moved from the cytoplasm into the matrix ATP is not needed for this. 

Ethylene glycol, an industrial solvent and an antifreeze compound, is involved in accidental and intentional poisonings. This compound is initially oxidized by alcohol dehydrogenase and then further biotransformed to oxalic acid and other products. Oxalate crystals are found in various tissues of the body and are excreted by the kidney. Deposition of oxalate crystals in the kidney causes renal toxicity. Ethylene glycol is also a CNS depressant. In cases of ethylene glycol poisoning, ethanol is administered to reduce the first step in the biotransformation of ethylene glycol and, thereby, prevent the formation of oxalate and other products. 

---